图 1.

CCK8法检测fAβ_25-35与SFN对BV-2细胞活性的影响

CCK8 assay for assessing the effects of Aβ_25-35 and SFN on BV-2 cell viability. A: BV-2 cell viability following treatment with different concentrations of fAβ_25-35 for 24 h (**P < 0.01, ****P < 0.0001 vs control group). B: BV-2 cell viability following treatment with different concentrations of SFN for 24 h (^*P < 0.05, ^**P < 0.01, ^***P < 0.001 vs control group). C: BV-2 cell viability following treatments with vehicle, fAβ_25-35 (50 μmol/L) and fAβ_25-35 (50 μmol/L) +SFN (10 μmol/L) for 24 h (^****P < 0.0001).